Literature DB >> 28770339

Evaluating vertebral artery dominancy before T4 lung cancer surgery requiring subclavian artery reconstruction.

Yasuo Sekine1, Yukio Saitoh2, Mitsuru Yoshino2, Eitetsu Koh3, Atsushi Hata3, Terunaga Inage2, Hidemi Suzuki3,4, Ichiro Yoshino4.   

Abstract

PURPOSES: To evaluate vertebral artery (VA) dominancy and the risk of brain infarction in T4 lung cancer patients with tumor invasion into the subclavian artery.
METHODS: We reconstructed the subclavian artery in 10 patients with T4 non-small cell lung cancer. The histological stages were IIIA in eight patients and IIIB in two patients. We evaluated the VA dominancy by performing a four-vessel study preoperatively and investigated the relationship between the methods of VA treatment and postoperative brain complications, retrospectively.
RESULTS: Seven patients had a superior sulcus tumor (SST) and three had direct invasion into the mediastinum. Based on the tumor location, a transmanublial approach was used in five patients and a posterolateral hook incision was used in the other five. All subclavian artery (SA) reconstructions were done using an artificial woven graft. Preoperative angiography of the VA revealed poor development of the contralateral side in two patients. One of these patients suffered a severe brain infarction on postoperative day 2, which proved fatal. In the other patient, the VA was connected to the left SA graft by a side-to-end anastomosis and there was no postoperative brain complication.
CONCLUSIONS: Preoperative SA and VA angiography is mandatory for identifying the need for VA reconstruction in lung cancer patients with major arterial invasion.

Entities:  

Keywords:  Lung cancer surgery; Subclavian artery; T4 cancer; Vascular reconstruction

Mesh:

Year:  2017        PMID: 28770339     DOI: 10.1007/s00595-017-1573-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

1.  Vertebral artery transposition for revascularization of the posterior circulation: a critical assessment of temporary and permanent complications and outcomes.

Authors:  Leonardo Rangel-Castilla; M Yashar S Kalani; Katherine Cronk; Joseph M Zabramski; Jonathan J Russin; Robert F Spetzler
Journal:  J Neurosurg       Date:  2014-11-14       Impact factor: 5.115

2.  Resection of apical lung carcinoma involving the vertebral artery.

Authors:  Tatsuaki Watanabe; Yoshinori Okada; Akira Sakurada; Tetsu Sado; Yasushi Matsuda; Hiroaki Shimizu; Tatsuro Fukuhara; Takashi Kondo
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

3.  Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.

Authors:  Bedrettin Yildizeli; Philippe G Dartevelle; Elie Fadel; Sacha Mussot; Alain Chapelier
Journal:  Ann Thorac Surg       Date:  2008-10       Impact factor: 4.330

4.  Completely resected superior sulcus tumor and vascular reconstruction of vertebral and subclavian arteries.

Authors:  Naoya Ishibashi; Chiaki Endo; Yasushi Hoshikawa; Masafumi Noda; Yoshikatsu Saiki; Naotaka Motoyoshi; Yoshinori Okada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-25

5.  The surgical reconstruction of the proximal subclavian and vertebral artery.

Authors:  W H Edwards; J L Mulherin
Journal:  J Vasc Surg       Date:  1985-07       Impact factor: 4.268

6.  T4 lung tumors with infiltration of the thoracic aorta: is an operation reasonable?

Authors:  W Klepetko; W Wisser; T Bîrsan; P Mares; S Taghavi; N Kupilik; E Wolner
Journal:  Ann Thorac Surg       Date:  1999-02       Impact factor: 4.330

Review 7.  Extended resections of non-small cell lung cancers invading the aorta, pulmonary artery, left atrium, or esophagus: can they be justified?

Authors:  Emily S Reardon; David S Schrump
Journal:  Thorac Surg Clin       Date:  2014-09-11       Impact factor: 1.750

8.  Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.

Authors:  Hideo Kunitoh; Harubumi Kato; Masahiro Tsuboi; Taro Shibata; Hisao Asamura; Yukito Ichinose; Yukito Ichonose; Nobuyuki Katakami; Kanji Nagai; Tetsuya Mitsudomi; Akihide Matsumura; Ken Nakagawa; Hirohito Tada; Nagahiro Saijo
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

9.  Subclavian artery resection and reconstruction for thoracic inlet cancer: 25 years of experience.

Authors:  Benoit Lahon; Olaf Mercier; Elie Fadel; Sacha Mussot; Dominique Fabre; Sarah Hamdi; Thierry Le Chevalier; Philippe Dartevelle
Journal:  Ann Thorac Surg       Date:  2013-07-11       Impact factor: 4.330

10.  Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer.

Authors:  Kazuhiko Shien; Shinichi Toyooka; Katsuyuki Kiura; Keitaro Matsuo; Junichi Soh; Masaomi Yamane; Takahiro Oto; Mitsuhiro Takemoto; Hiroshi Date; Shinichiro Miyoshi
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.